Navigation Links
Aileron collaborates study in Nature: Stapled peptides inhibit Notch1 transcription factor
Date:11/11/2009

Peptides, without the limitations previously observed with upstream inhibitors of Notch.

"Transcription factors are among the most desirable and validated therapeutic targets in cancer, yet they are among the most elusive targets in cancer drug discovery," said James Bradner, MD,, Division Of Hematologic Neoplasia, Dana-Farber Cancer Institute. "Our research shows, for the first time, how assembly of the Notch multi-protein transcription factor complex can be inhibited in the nucleus of a cancer cell with a stapled peptide, leading to cancer cell death. Using stapled peptides to target transcription factors opens a potential new path for discovering novel and effective therapies for patients."

A growing body of research describes the critical role that transcription factors play in biological pathways implicated in a broad array of human diseases. In the past 25 years, for example, the 20 most-cited transcription factors have been referenced in the scientific literature an estimated 100,000 timesi. In cancer biology, it has been shown that more than 50% of T-cell acute lymphoblastic leukemias (T-ALL) have activating mutations in Notch . However, the vast majority of transcription factors lack an appropriate binding pocket for targeting by small molecules. Moreover, most transcription factors reside within cells and so are not suitable for antibody-based therapies. Stapled Peptides have now been shown to inhibit a previously-undruggable transcription factor at a therapeutically meaningful level.

"These results are tantamount to a declaration of open season on transcription factors," said Gregory L. Verdine, PhD, Erving Professor of Chemistry, Harvard University and co-chair of Aileron Therapeutics' scientific advisory board. "While the vast majority of transcription factors are not druggable with current small molecule or biologic modalities, many features of the protein-protein interaction represented by Notch are similar to other transcr
'/>"/>

Contact: Kathryn Morris
kathryn@kmorrispr.com
845-635-9828
Yates Public Relations
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Old Colony Elder Services Collaborates with The Charity Guild of Brockton to Offer "Special Foods for Special People" Program
2. UNTHSC Collaborates With Law Enforcement to Provide Alternatives to Dallas Prostitutes
3. WellPoint Collaborates with RedBrick Health to Create Integrated, Behavior-Based Wellness and Incentives Programs
4. Blue Cross and Blue Shield of Texas Collaborates With Five Blue Plans to Increase Transparency, Expand Access to Health Care Cost Information
5. Partnership Collaborates on HIE for Interoperability of Electronic Health Records and Patient Data in Ohio
6. Michigan State Medical Society Collaborates With Microsoft to Expand Health Care Technology in Michigan
7. Apollo Health Street Collaborates with Client to Develop a CCHIT-Certified 08 Ambulatory EMR
8. HealthCentral.com Collaborates With BreastCancer.org, Providing Quality Awareness Sponsorships to #1 Breast Cancer Resource Online
9. Impac Software Collaborates With the National Comprehensive Cancer Network to Improve Patient Care
10. Healthbase Collaborates with WellPoint to Bring Affordable Medical Tourism Solutions
11. Pathwork Diagnostics Collaborates With Guys and St Thomas on Tissue of Origin Test Validation in the UK
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2015)... New York, NY (PRWEB) February 28, 2015 ... DIY Phishing Kits Make It Easy For Scammers To Steal ... about anyone can get their hands on a DIY phishing ... But it also touched on another important point about ... ways these kits are often implemented, “like compromising legitimate content ...
(Date:2/28/2015)... 2015 “ Powermod ” was featured on ... a look at the latest and coolest technology products and ... NewsWatch and a technology expert, conducted the review and shared ... solutions. , Getting stuck with a low battery and no ... that people face on a daily basis. Even when a ...
(Date:2/28/2015)... Angeles, California (PRWEB) February 28, 2015 ... fully supported and showcased emerging brand at Houston ... held in Las Vegas sending its executive delegates ... Director of Business Development and Training Randolph Clarito. ... Association (IFA), was held last February 4-7 and ...
(Date:2/27/2015)... 2015 Just a little over two ... suffering from Sjögren’s Syndrome after a new autoantibody associated ... the University of Buffalo and Immco Diagnostics, Inc. After ... to develop a new diagnostic test that ... new autoantibodies. Researchers aimed to develop a test that ...
(Date:2/27/2015)... 27, 2015 Altec Products, Inc., announced ... been chosen as their doc-link for Dynamics Partner of ... other complimentary solutions for their customers in all different ... unions. Altec and BPW have worked side-by-side to successfully ... Dynamics GP. , “We are so impressed by the ...
Breaking Medicine News(10 mins):Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 2Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 3Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 4Health News:Solutions to Keep Phones Charged were Featured on NewsWatch Television on January 29, 2015 2Health News:1Heart Caregiver Services Showcases Emerging Brand at Franchise Expo South and IFA Annual Convention 2Health News:1Heart Caregiver Services Showcases Emerging Brand at Franchise Expo South and IFA Annual Convention 3Health News:Breakthrough Blood Test for Early Detection of Sjögren’s Syndrome Now Available 2Health News:Altec Announces 2014 doc-link for Dynamics Partner of the Year Award Recipient 2Health News:Altec Announces 2014 doc-link for Dynamics Partner of the Year Award Recipient 3
... The language that doctors use with low-income, rural patients ... in clinical trials testing new cancer treatments, a new ... used to help explain what happens in such trials ... to participate. "Physicians have to communicate about medicine ...
... number of diagnostic and therapeutic options for patients with ... approach based on the clinical situation and molecular characteristics ... options for the benefit of the patients within an ... the conference. , "The number of diagnostic and therapeutic ...
... , MONDAY, Dec. 20 (HealthDay News) -- New research suggests that ... a fatty acid that may lower the risk of type 2 ... the study in the Dec. 21 issue of the Annals ... of this fatty acid reduce their odds of diabetes by 62 ...
... , TUESDAY, Dec. 21 (HealthDay News) -- Certain cells in ... to an animal study that might one day lead to ... mice, a team at the Joslin Diabetes Center in Boston ... cells in subcutaneous (just beneath the skin) white fat tissue ...
... may be harder to quit, particularly for some teens ... according to a study by a team of researchers. ... smokers of menthol cigarettes have a lower quit rate ... smokers. One possible reason suggested in the report is ...
... Black people with early stage liver cancer were more ... to a new study from the University of Michigan Comprehensive ... white liver cancer patients were alive but only 15 percent ... Median survival times ranged from 10 months for whites and ...
Cached Medicine News:Health News:Use the right metaphor to get patients to enroll in clinical trials 2Health News:Use the right metaphor to get patients to enroll in clinical trials 3Health News:Use the right metaphor to get patients to enroll in clinical trials 4Health News:European Multidisciplinary Conference in Thoracic Oncology 2Health News:Whole-Fat Dairy Products May Lower Type 2 Diabetes Risk: Study 2Health News:Whole-Fat Dairy Products May Lower Type 2 Diabetes Risk: Study 3Health News:Quitting menthol cigarettes may be harder for some smokers 2Health News:Blacks with liver cancer more likely to die, study finds 2
(Date:2/27/2015)... --  Synageva BioPharma Corp. (Synageva) (NASDAQ: ... products for rare diseases, joins the National Organization ... Rare Diseases™ (EURORDIS™), The Global Genes Project™, and ... Day. On the last day of ... participants conduct special events to raise awareness and ...
(Date:2/27/2015)... , February 27, 2015 ... sein bahnbrechendes Überwachungssystem für kongestive Herzinsuffizienz (CHF) ... -     ... die ein neuartiges Herzüberwachungssystem für Patienten mit ... bekannt, dass sie ein Finanzierungsvorhaben über 5 ...
(Date:2/26/2015)... , Feb. 27, 2015  Finesse expands office in ... Solutions announced the expansion of its operations in ... for mid-March and access for customers is expected shortly ... and located adjacent to the current office, the new ... engineering team and allow Finesse to bring on more ...
Breaking Medicine Technology:Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 2Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 3Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 4Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 5Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 6Vectorious Medical Technologies schließt Finanzierungsvorhaben über 5 Mio. USD ab 2New Finesse Office in United Kingdom 2
... Data on six products from Pharmion's pipeline provide ... III,data on use of Thalidomide to treat multiple ... Pharmion,Corporation reported today that data from 18 abstracts ... will be,presented or published at the American Society ...
... HANOVER, Germany--(BUSINESS WIRE)--Jun 1, 2007 - A ... to battle prostate,cancer promises new hope for ... clinical study will be presented to an,international ... American,Society for Clinical Oncology (ASCO) in Chicago, ...
Cached Medicine Technology:Pharmion to Present Clinical Data on Commercial and Pipeline,Products at 2007 American Society of Clinical Oncology (ASCO),Meeting 2Pharmion to Present Clinical Data on Commercial and Pipeline,Products at 2007 American Society of Clinical Oncology (ASCO),Meeting 3Pharmion to Present Clinical Data on Commercial and Pipeline,Products at 2007 American Society of Clinical Oncology (ASCO),Meeting 4Pharmion to Present Clinical Data on Commercial and Pipeline,Products at 2007 American Society of Clinical Oncology (ASCO),Meeting 5Pharmion to Present Clinical Data on Commercial and Pipeline,Products at 2007 American Society of Clinical Oncology (ASCO),Meeting 6Pharmion to Present Clinical Data on Commercial and Pipeline,Products at 2007 American Society of Clinical Oncology (ASCO),Meeting 7Vakzine Projekt Management Reports Positive Clinical Trial Results,With Their Therapeutic Prostate Cancer Vaccine VPM4001 2
Enzyme immunoassay for the quantitative determination of Gliadin-IgA antibodies in serum and plasma. This kit provides specific determination of gliadin antibodies by using highly purified gliadin....
... Enzyme-linked immunosorbent assay method for the ... gliadin in human serum. The results of ... as an aid in the diagnosis of ... antibodies including Coeliac Disease. Levels of these ...
... The AX-4280 can operate with batches ... with the addition of optional Load/Unload ... The AX-4280 is a benchtop ... automation and reliability providing the laboratory ...
Anti Gliadin IgA Enzyme Immunosay for quantitative determination of Gliadin-IgG antibodies in serum....
Medicine Products: